Related references
Note: Only part of the references are listed.TSVdb: a web-tool for TCGA splicing variants analysis
Wenjie Sun et al.
BMC GENOMICS (2018)
The downregulation of IncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer
Yi Gu et al.
PLOS ONE (2018)
Feature of amenorrhea in postoperative tamoxifen users with breast cancer
Hoon Kim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
A subcellular map of the human proteome
Peter J. Thul et al.
SCIENCE (2017)
Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation
Seung Eun Lee et al.
THYROID (2017)
ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer (vol 17, 631, 2016)
Seok Yang et al.
BMC GENOMICS (2016)
BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma
Andre Uchimura Bastos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways
Bhupendra Singh et al.
CARCINOGENESIS (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up
Thais Gomes de Melo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Cancer
Martha A. Zeiger et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity
Melissa Runge-Morris et al.
DRUG METABOLISM REVIEWS (2013)
Follicular Variant of Papillary Thyroid Carcinoma is a Unique Clinical Entity: A Population-Based Study of 10,740 Cases
Xiao-Min Yu et al.
THYROID (2013)
The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer
Tae Hyuk Kim et al.
CANCER (2012)
Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients
M. Brassard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma
Kuai-Lu Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Papillary thyroid carcinoma: Factors influencing recurrence and survival
Antonio Toniato et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines
SK Krueger et al.
DRUG METABOLISM REVIEWS (2006)
Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin
P Parte et al.
DRUG METABOLISM AND DISPOSITION (2005)
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism
SK Krueger et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Dissecting tBHQ induced ARE-driven gene expression through long and short oligonucleotide arrays
J Li et al.
PHYSIOLOGICAL GENOMICS (2005)
Potential roles of flavin-containing monooxygenases in sulfoxidation reactions of L-methionine, N-acetyl-L-methionine and peptides containing L-methionine
AA Elfarra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Genetic variability at the human FMO1 locus:: Significance of a basal promoter Yin Yang 1 element polymorphism (FMO1*6)
RN Hines et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans
B Furnes et al.
DRUG METABOLISM AND DISPOSITION (2003)
An overview of the mechanism, substrate specificities, and structure of FMOs
DM Ziegler
DRUG METABOLISM REVIEWS (2002)
Regulation of flavin-containing monooxygenase 1 expression by Ying Yang 1 and hepatic nuclear factors 1 and 4
ZH Luo et al.
MOLECULAR PHARMACOLOGY (2001)
Share Paper
